RG-6333 enhances antitumor activity of glofitamab in preclinical non-Hodgkin lymphoma models
Jan. 3, 2023
Non-Hodgkin lymphomas (NHLs) originate from a clonal expansion of B cells (85%), T cells/NK cells (15%) or macrophages (~1%) due to an accumulation of genetic lesions in tumor suppressor genes. Approximately 82,000 new cases of NHL were diagnosed in 2021.